Do analysts prefer SXTPW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score 60 Degrees Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation and earnings, SXTPW or SISI?

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio 60 Degrees Pharmaceuticals $1.00M N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Do analysts recommend BFRIW or SISI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biofrontera 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has higher earnings & valuation, BFRIW or SISI?

Biofrontera has higher revenue and earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biofrontera $43.20M N/A N/A N/A N/A Shineco $9.60M 0.00 -$22.45M -$204.00 N/A

Do analysts rate SISI or CALA?

Given Calithera Biosciences' higher possible upside, analysts plainly believe Calithera Biosciences is more favorable than Shineco. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Calithera Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger valuation and earnings, SISI or CALA?

Shineco has higher revenue and earnings than Calithera Biosciences. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A Calithera Biosciences N/A N/A -$39.65M N/A N/A

Do analysts recommend SISI or CINGW?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Cingulate 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has stronger earnings and valuation, SISI or CINGW?

Cingulate has lower revenue, but higher earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A Cingulate N/A N/A N/A N/A N/A

Do analysts prefer SISI or CMRAW?

Given Comera Life Sciences' higher probable upside, analysts clearly believe Comera Life Sciences is more favorable than Shineco. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Shineco 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Comera Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has preferable valuation and earnings, SISI or CMRAW?

Comera Life Sciences has lower revenue, but higher earnings than Shineco. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Shineco $9.60M 0.00 -$22.45M -$204.00 N/A Comera Life Sciences $1.00M N/A N/A N/A N/A

Shineco (SISI) Competitors

$0.0003 0.00 (0.00%)

As of 08/7/2026 11:20 AM Eastern

Compare

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Shineco stock or one of its competitors? Shineco's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Shineco compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, dividends, media sentiment, institutional ownership and risk.

In the previous week, 60 Degrees Pharmaceuticals had 2 more articles in the media than Shineco. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 0 mentions for Shineco. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
60 Degrees Pharmaceuticals	Neutral
Shineco	Neutral

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

60 Degrees Pharmaceuticals has higher earnings, but lower revenue than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
60 Degrees Pharmaceuticals	$1.00M	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
60 Degrees Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

60 Degrees Pharmaceuticals has a net margin of 0.00% compared to Shineco's net margin of -380.55%. 60 Degrees Pharmaceuticals' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
60 Degrees Pharmaceuticals	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Summary

60 Degrees Pharmaceuticals and Shineco tied by winning 4 of the 8 factors compared between the two stocks.

How does Shineco compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Shineco (NASDAQ:SISI) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, media sentiment, valuation, dividends, earnings, institutional ownership and analyst recommendations.

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Biofrontera's average media sentiment score of 0.00 equaled Shineco'saverage media sentiment score.

Company	Overall Sentiment
Biofrontera	Neutral
Shineco	Neutral

Biofrontera has higher revenue and earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biofrontera	$43.20M	N/A	N/A	N/A	N/A
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A

Biofrontera has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Biofrontera's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biofrontera	N/A	N/A	N/A
Shineco	-380.55%	-79.89%	-33.01%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biofrontera	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Biofrontera beats Shineco on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Calithera Biosciences?

Shineco (NASDAQ:SISI) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, media sentiment, risk, institutional ownership, dividends, profitability, valuation and analyst recommendations.

Given Calithera Biosciences' higher possible upside, analysts plainly believe Calithera Biosciences is more favorable than Shineco.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Calithera Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Calithera Biosciences has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Calithera Biosciences' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Calithera Biosciences	N/A	N/A	N/A

4.1% of Shineco shares are held by institutional investors. 0.0% of Shineco shares are held by insiders. Comparatively, 6.6% of Calithera Biosciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Shineco has higher revenue and earnings than Calithera Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
Calithera Biosciences	N/A	N/A	-$39.65M	N/A	N/A

In the previous week, Shineco's average media sentiment score of 0.00 equaled Calithera Biosciences'average media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
Calithera Biosciences	Neutral

Shineco has a beta of -1.61, indicating that its stock price is 261% less volatile than the broader market. Comparatively, Calithera Biosciences has a beta of -1.23, indicating that its stock price is 223% less volatile than the broader market.

Summary

Calithera Biosciences beats Shineco on 6 of the 11 factors compared between the two stocks.

How does Shineco compare to Cingulate?

Shineco (NASDAQ:SISI) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, media sentiment, earnings, institutional ownership, dividends, analyst recommendations, valuation and risk.

Cingulate has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Cingulate's return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Cingulate	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Cingulate	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Cingulate has lower revenue, but higher earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
Cingulate	N/A	N/A	N/A	N/A	N/A

In the previous week, Shineco's average media sentiment score of 0.00 equaled Cingulate'saverage media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
Cingulate	Neutral

Summary

Shineco beats Cingulate on 4 of the 7 factors compared between the two stocks.

How does Shineco compare to Comera Life Sciences?

Shineco (NASDAQ:SISI) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

Comera Life Sciences has a net margin of 0.00% compared to Shineco's net margin of -380.55%. Comera Life Sciences' return on equity of 0.00% beat Shineco's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Shineco	-380.55%	-79.89%	-33.01%
Comera Life Sciences	N/A	N/A	N/A

Comera Life Sciences has lower revenue, but higher earnings than Shineco.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Shineco	$9.60M	0.00	-$22.45M	-$204.00	N/A
Comera Life Sciences	$1.00M	N/A	N/A	N/A	N/A

4.1% of Shineco shares are owned by institutional investors. 0.0% of Shineco shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

In the previous week, Shineco's average media sentiment score of 0.00 equaled Comera Life Sciences'average media sentiment score.

Company	Overall Sentiment
Shineco	Neutral
Comera Life Sciences	Neutral

Given Comera Life Sciences' higher probable upside, analysts clearly believe Comera Life Sciences is more favorable than Shineco.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Shineco	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Comera Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Shineco and Comera Life Sciences tied by winning 4 of the 8 factors compared between the two stocks.

Get Shineco News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SISI vs. The Competition

Export

Metric	Shineco	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$11.84B	$7.02B	$12.98B
Dividend Yield	N/A	2.69%	2.58%	10.07%
P/E Ratio	0.00	788.51	269.20	24.72
Price / Sales	0.00	740.84	588.81	98.32
Price / Cash	N/A	15.12	28.89	37.42
Price / Book	0.00	10.33	11.27	6.42
Net Income	-$22.45M	$2.77B	$3.45B	$347.03M
7 Day Performance	N/A	0.84%	1.92%	0.69%
1 Month Performance	N/A	-1.61%	-0.58%	-0.90%
1 Year Performance	N/A	183.22%	75.49%	21.87%

Shineco Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SISI Shineco	N/A	$0.00 flat	N/A	-99.8%	$0.00	$9.60M	N/A	70
SXTPW 60 Degrees Pharmaceuticals	N/A	$0.03 +1.2%	N/A	-77.2%	$0.00	$1.00M	N/A	2	Positive News
BFRIW Biofrontera	N/A	$0.03 flat	N/A	N/A	$0.00	$43.20M	N/A	70
CALA Calithera Biosciences	N/A	$0.00 -66.7%	N/A	N/A	$0.00	N/A	N/A	60	Upcoming Earnings Gap Down
CINGW Cingulate	N/A	$0.01 +1.1%	N/A	-90.1%	$0.00	N/A	N/A	20	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SISI) was last updated on 8/11/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

How does Shineco compare to 60 Degrees Pharmaceuticals?

Summary

How does Shineco compare to Biofrontera?

Summary

How does Shineco compare to Calithera Biosciences?

Summary

How does Shineco compare to Cingulate?

Summary

How does Shineco compare to Comera Life Sciences?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Shineco (SISI) Competitors

SISI vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

How does Shineco compare to 60 Degrees Pharmaceuticals?

Does the media favor SXTPW or SISI?

Do insiders & institutionals hold more shares of SXTPW or SISI?

Which has better valuation and earnings, SXTPW or SISI?

Do analysts prefer SXTPW or SISI?

Is SXTPW or SISI more profitable?

Summary

How does Shineco compare to Biofrontera?

Do insiders & institutionals have more ownership in BFRIW or SISI?

Does the media prefer BFRIW or SISI?

Which has higher earnings & valuation, BFRIW or SISI?

Is BFRIW or SISI more profitable?

Do analysts recommend BFRIW or SISI?

Summary

How does Shineco compare to Calithera Biosciences?

Do analysts rate SISI or CALA?

Is SISI or CALA more profitable?

Do insiders and institutionals hold more shares of SISI or CALA?

Which has stronger valuation and earnings, SISI or CALA?

Does the media prefer SISI or CALA?

Which has more volatility & risk, SISI or CALA?

Summary

How does Shineco compare to Cingulate?

Is SISI or CINGW more profitable?

Do analysts recommend SISI or CINGW?

Do institutionals & insiders have more ownership in SISI or CINGW?

Which has stronger earnings and valuation, SISI or CINGW?

Does the media refer more to SISI or CINGW?

Summary

How does Shineco compare to Comera Life Sciences?

Is SISI or CMRAW more profitable?

Which has preferable valuation and earnings, SISI or CMRAW?

Do institutionals & insiders believe in SISI or CMRAW?

Does the media refer more to SISI or CMRAW?

Do analysts prefer SISI or CMRAW?

Summary

Media Sentiment Over Time

SISI vs. The Competition

Shineco Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools